Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

Inclusion Criteria: * Veterans deployed to the Gulf War theatre of operations between 1990 and 1991. * Veterans who report at least 2 of the following 3 symptoms that began in 1990 or thereafter, that lasted for more than 6 months, and that are present at the time of screening: 1) fatigue that limited usual activity, 2) musculoskeletal pain involving 2 or more regions of the body, 3) cognitive symptoms (memory, concentration, or attentional difficulties by self-report) * Stable on medication regimen (no change in last 4 weeks) and no anticipated change in medication during study. * Able to provide informed consent for study participation. Exclusion Criteria: * Subjects with a history of clinically significant neurological, metabolic, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, and/or urological disorders (e.g. unstable angina, seizures, cerebrovascular accident, decompensated congestive heart failure, central nervous system (CNS) infection, cancer \[other than non-melanoma skin cancer\], or history of HIV seropositivity), which would pose a risk to the patient if s/he were to participate in the study or that might confound the results of the study. * Concurrent enrollment in another clinical trial. * Pregnant women or women of child-bearing potential who are not surgically-sterile or not using appropriate methods of birth control. * Use of oral contraceptives or other hormonal supplementation such as estrogen \[although early studies suggest…